White Papers

Navigating the patient treatment journey is like solving a complex puzzle for the pharmaceutical industry. At every turn, there are challenges, most notably the phenomenon of patient treatment abandonment. Imagine spending years developing a drug that could potentially save thousands of lives, only to find out that a significant portion of patients who should be

There’s lots of obstacles to ensure patients can access clinically appropriate therapy, and even once they do start treatment, questions arise as to whether they’ll stay on the treatment, and even how effective it is. Solving abandonment and discontinuation in specialty drugs can be nonviable, unless you have the in-depth data to identify the cause,